Oracle and other software stocks are undergoing a major sell-off.
Down big off its high, the sell-off in Oracle could be a buying opportunity for risk-tolerant investors.
The database of 200 million protein-structure predictions now includes homodimers, adding new biological relevance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results